US 12121288
Combination tumor treatment
granted A61KA61K47/32A61K9/0019
Quick answer
US patent 12121288 (Combination tumor treatment) held by Regents of the University of Minnesota expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K47/32, A61K9/0019, A61K9/0024, A61K9/16